JP2020203894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020203894A5 JP2020203894A5 JP2020135954A JP2020135954A JP2020203894A5 JP 2020203894 A5 JP2020203894 A5 JP 2020203894A5 JP 2020135954 A JP2020135954 A JP 2020135954A JP 2020135954 A JP2020135954 A JP 2020135954A JP 2020203894 A5 JP2020203894 A5 JP 2020203894A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- cardiac
- deletion
- seq
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022178566A JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13151593 | 2013-01-17 | ||
| EP13151593.4 | 2013-01-17 | ||
| JP2015553072A JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Division JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178566A Division JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020203894A JP2020203894A (ja) | 2020-12-24 |
| JP2020203894A5 true JP2020203894A5 (enExample) | 2025-02-04 |
| JP7685737B2 JP7685737B2 (ja) | 2025-05-30 |
Family
ID=47559322
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2020135954A Active JP7685737B2 (ja) | 2013-01-17 | 2020-08-11 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2022178566A Pending JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553072A Active JP6809789B2 (ja) | 2013-01-17 | 2014-01-16 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022178566A Pending JP2023025005A (ja) | 2013-01-17 | 2022-11-08 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
| JP2025092726A Pending JP2025143268A (ja) | 2013-01-17 | 2025-06-03 | 疾患の治療または予防に用いるためのファクター１およびファクター２タンパク質、およびその阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10369198B2 (enExample) |
| EP (2) | EP2945642B1 (enExample) |
| JP (4) | JP6809789B2 (enExample) |
| CN (6) | CN104968361B (enExample) |
| CA (1) | CA2898128A1 (enExample) |
| DK (1) | DK2945642T3 (enExample) |
| ES (1) | ES2986021T3 (enExample) |
| FI (1) | FI2945642T3 (enExample) |
| HR (1) | HRP20240623T1 (enExample) |
| HU (1) | HUE068364T2 (enExample) |
| LT (1) | LT2945642T (enExample) |
| PL (1) | PL2945642T3 (enExample) |
| PT (1) | PT2945642T (enExample) |
| RS (1) | RS65553B1 (enExample) |
| SI (1) | SI2945642T1 (enExample) |
| WO (1) | WO2014111458A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2945642T (pt) * | 2013-01-17 | 2024-05-27 | Medizinische Hochschule Hannover | Proteína do fator 1 para utilização no tratamento ou prevenção de doenças |
| CN105934249A (zh) | 2013-11-21 | 2016-09-07 | 布里格姆及妇女医院股份有限公司 | 用于治疗肺高压的组合物和方法 |
| WO2016019368A1 (en) * | 2014-08-01 | 2016-02-04 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to treatment of pulmonary arterial hypertension |
| US10435757B1 (en) | 2016-06-15 | 2019-10-08 | University Of South Florida | Methods of measuring C19MC miRNA in a post-natal tissue and uses thereof |
| CN108802372B (zh) * | 2018-06-19 | 2021-05-11 | 上海伦泽生物科技有限公司 | 检测人血清中内质网膜蛋白复合体亚单位10的试剂盒 |
| EP4087489B1 (en) | 2020-01-08 | 2025-05-14 | Vitruvia Holdings Inc. | Methods and computing system for processing ultrasound image to determine health of subdermal tissue |
| MX2022008727A (es) * | 2020-01-21 | 2022-10-07 | Boehringer Ingelheim Int | Factor de crecimiento derivado de mieloide para su uso en el tratamiento o la prevencion de fibrosis, hipertrofia o insuficiencia cardiaca. |
| CN114149498B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在防治2型糖尿病中的应用 |
| CN114149499B (zh) * | 2020-09-07 | 2023-12-05 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体及其在治疗和/或预防肥胖症中的应用 |
| CN114149500B (zh) * | 2020-09-07 | 2023-12-01 | 复旦大学附属华山医院 | 抗人emc10的单克隆抗体在制备治疗和/或预防脂肪肝的产品中的应用 |
| US20250325704A1 (en) | 2020-12-23 | 2025-10-23 | Boehringer Ingelheim International Gmbh | Viral capsid proteins with specificity to heart tissue cells |
| JP2024523707A (ja) * | 2021-07-08 | 2024-06-28 | テナヤ セラピューティクス， インコーポレイテッド | 遺伝子治療のための最適化された発現カセット |
| JP2025518285A (ja) | 2022-06-03 | 2025-06-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 骨髄由来増殖因子の組換え発現 |
| TW202426036A (zh) | 2022-09-08 | 2024-07-01 | 德商百靈佳殷格翰國際有限公司 | 用於治療心因性休克的骨髓衍生性生長因子（二） |
| WO2025047991A1 (en) | 2023-09-01 | 2025-03-06 | Boehringer Ingelheim International Gmbh | Myeloid-derived growth factor for use in treating or preventing a liver disorder |
| WO2025073372A1 (en) | 2023-10-05 | 2025-04-10 | Boehringer Ingelheim International Gmbh | Recombinant expression of myeloid-derived growth factor |
| WO2025120204A1 (en) | 2023-12-06 | 2025-06-12 | Boehringer Ingelheim International Gmbh | Novel formulation comprising myeloid-derived growth factor |
| CN120738287B (zh) * | 2025-07-03 | 2026-02-24 | 广州医科大学附属妇女儿童医疗中心 | 急性低灌注动物模型的构建方法及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
| AU717542B2 (en) | 1996-06-11 | 2000-03-30 | Merck & Co., Inc. | Synthetic hepatitis C genes |
| JP2001506484A (ja) * | 1996-09-13 | 2001-05-22 | 財団法人相模中央化学研究所 | 分泌シグナル配列を有するヒト蛋白質およびそれをコードするｄｎａ |
| CA2265923A1 (en) | 1996-09-13 | 1998-03-19 | Sagami Chemical Research Center | Human proteins having secretory signal sequences and dnas encoding these proteins |
| WO2002008284A2 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| HUP0001964A3 (en) * | 1997-01-29 | 2002-01-28 | Cornell Res Foundation Inc Ith | Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| AU4761100A (en) | 1999-05-26 | 2000-12-18 | Kalle Saksela | Methods and materials for generating sh3 domains with tailored binding properties |
| DK1212417T3 (da) * | 1999-06-02 | 2008-09-01 | Genentech Inc | Fremmelse eller inhibering af angiogenese og vaskularisering |
| CA2381985A1 (en) * | 1999-08-16 | 2001-02-22 | Universita'degli Studi Di Siena | Vegf-d and angiogenic use thereof |
| WO2002081681A1 (fr) * | 2001-03-30 | 2002-10-17 | Chugai Seiyaku Kabushiki Kaisha | Nouvelle utilisation de la cytokine sf20 |
| DE10119804A1 (de) * | 2001-04-23 | 2002-10-24 | Brahms Ag | Entzündungsspezifische Peptide und deren Verwendungen |
| US7452968B2 (en) * | 2003-01-02 | 2008-11-18 | University Of Southern California | Secreted protein factor and cell membrane-bound splice variant |
| WO2004069173A2 (en) * | 2003-01-31 | 2004-08-19 | The Trustees Of The University Of Pennsylvania | Methods for modulating an inflammatory response |
| US8486438B2 (en) | 2004-01-29 | 2013-07-16 | Brown University | Methods for progenitor cell recruitment and isolation |
| CN101160055A (zh) * | 2005-02-16 | 2008-04-09 | 莱蒂恩公司 | 慢病毒载体及其用途 |
| US20080004232A1 (en) * | 2006-05-09 | 2008-01-03 | John Wilkins | Characterization of c19orf10, a Novel Synovial Protein |
| EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| EP2130547A1 (en) * | 2008-06-06 | 2009-12-09 | Giuliani International Limited | IL-25 for use in the treatment of inflammatory diseases |
| MX336152B (es) * | 2009-08-29 | 2016-01-08 | Abbvie Inc | Proteinas terapeutico de union a dll4. |
| WO2011094446A1 (en) * | 2010-01-27 | 2011-08-04 | Neumedicines, Inc | A method for treating brain cancer using a novel tumor suppressor gene and secreted factor |
| KR20120095063A (ko) * | 2011-02-18 | 2012-08-28 | 가톨릭대학교 산학협력단 | ＩＬ-27로 유도된 ｐ53을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 |
| PT2945642T (pt) * | 2013-01-17 | 2024-05-27 | Medizinische Hochschule Hannover | Proteína do fator 1 para utilização no tratamento ou prevenção de doenças |
-
2014
- 2014-01-16 PT PT147008726T patent/PT2945642T/pt unknown
- 2014-01-16 HR HRP20240623TT patent/HRP20240623T1/hr unknown
- 2014-01-16 CN CN201480005079.5A patent/CN104968361B/zh active Active
- 2014-01-16 CN CN201911137854.3A patent/CN110922468B/zh active Active
- 2014-01-16 CN CN201911137853.9A patent/CN111100197B/zh active Active
- 2014-01-16 WO PCT/EP2014/050788 patent/WO2014111458A2/en not_active Ceased
- 2014-01-16 EP EP14700872.6A patent/EP2945642B1/en active Active
- 2014-01-16 CA CA2898128A patent/CA2898128A1/en active Pending
- 2014-01-16 US US14/759,852 patent/US10369198B2/en active Active
- 2014-01-16 SI SI201432073T patent/SI2945642T1/sl unknown
- 2014-01-16 ES ES14700872T patent/ES2986021T3/es active Active
- 2014-01-16 RS RS20240548A patent/RS65553B1/sr unknown
- 2014-01-16 CN CN201911124174.8A patent/CN110894226A/zh active Pending
- 2014-01-16 CN CN201911138039.9A patent/CN110922467A/zh active Pending
- 2014-01-16 PL PL14700872.6T patent/PL2945642T3/pl unknown
- 2014-01-16 EP EP20178045.9A patent/EP3747457A3/en active Pending
- 2014-01-16 FI FIEP14700872.6T patent/FI2945642T3/fi active
- 2014-01-16 HU HUE14700872A patent/HUE068364T2/hu unknown
- 2014-01-16 CN CN201911137855.8A patent/CN110903378A/zh active Pending
- 2014-01-16 LT LTEPPCT/EP2014/050788T patent/LT2945642T/lt unknown
- 2014-01-16 JP JP2015553072A patent/JP6809789B2/ja active Active
- 2014-01-16 DK DK14700872.6T patent/DK2945642T3/da active
-
2020
- 2020-08-11 JP JP2020135954A patent/JP7685737B2/ja active Active
-
2022
- 2022-11-08 JP JP2022178566A patent/JP2023025005A/ja active Pending
-
2025
- 2025-06-03 JP JP2025092726A patent/JP2025143268A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020203894A5 (enExample) | ||
| JP2022115876A5 (enExample) | ||
| JP2023025005A5 (enExample) | ||
| ES2313166T3 (es) | Proteina de fusion de proteinas reguladoras/accesorias del vih. | |
| JP2019526580A5 (enExample) | ||
| RU2012107671A (ru) | Композиция для лечения инфекции вирусом гепатита в | |
| JP6929272B2 (ja) | 疾患処置のための方法 | |
| JP2024177497A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2020536489A5 (enExample) | ||
| JP2019521692A5 (enExample) | ||
| JP2020527167A5 (enExample) | ||
| JP2025084850A (ja) | ハンタウイルス抗原性組成物 | |
| JP2021500880A5 (enExample) | ||
| JPWO2020223362A5 (enExample) | ||
| JPWO2020223356A5 (enExample) | ||
| JP2018516599A (ja) | ポックスウイルス由来のプロモーターおよびそれを含むベクター | |
| JP2020535203A5 (enExample) | ||
| JP2020536519A5 (enExample) | ||
| JP4831551B2 (ja) | 非虚血性心筋障害に対する医薬 | |
| JPWO2020038473A5 (enExample) | ||
| WO2022025178A1 (ja) | ＲＥＩＣ／Ｄｋｋ－３遺伝子を含むＥＧＦＲ遺伝子変異陽性肺癌の治療薬 | |
| JP6640717B2 (ja) | レトロウイルス複製ベクターと関連する免疫抑制成分 | |
| JPWO2022015418A5 (enExample) | ||
| JPWO2022010813A5 (enExample) |